Dr. Reddy's Laboratories to buy Louisiana facility

Recs

0

Dr. Reddy's Laboratories Ltd., an India-based pharmaceuticals company, said Tuesday it will buy chemical company BASF's pharmaceutical contract manufacturing business and facility in Shreveport, La.

Financial terms were not disclosed. The deal is expected to close within Dr. Reddy's first fiscal quarter, which ends in June.

The facility is designed to make solid, semi-solid and liquid dosage forms. It currently employs about 150 people and generated revenue of $43 million in 2007.

Shares of Dr. Reddy's fell 3 cents to close at $15.41.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 633144, ~/articles/articlehandler.aspx, 12/2/2008 6:01:03 AM,

Sign up for FREE Motley Fool site access to keep reading:

“Dr. Reddy's Laboratories to buy Louisiana facility”

Signing up allows you to comment on articles and on the discussion boards.

It's completely FREE and will take only 10 seconds.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Most Recent

Most Recommended

Market Summary

S&P 500816.21 -8.93%
DJIA8,149.09 -7.70%
NASD1,398.07 -8.95%
Updated: 4:04:56 PM
Sponsored by:

Related Tickers

Dr. Reddy's Laboratories Limited (ADR)

CAPS Rating 5/5 Stars

$8.70

-0.17 (-1.92%)

Outperform331

Underperform18

Rate This Stock